• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支气管扩张剂:β2 激动剂与茶碱的比较

Bronchodilators: beta 2 agonists versus theophylline.

作者信息

Scott G W

机构信息

Guy's Hospital, London, United Kingdom.

出版信息

Ann Acad Med Singap. 1987 Apr;16(2):228-9.

PMID:2891340
Abstract

Beta 2 agonists are best administered by inhalation since this route provides maximum therapeutic effect with minimum side effects. Plasma levels are lower and muscle cramps, tachycardia and tremor less common. Inhalation may be carried out by use pressurised inhalers (with various modification if necessary), by a Rotahaler with Salbutamol powder, and by nebulisers. All have their uses. Apart from their immediate bronchodilator effect, it is customary to give Beta 2-agonists routinely before inhalation beclomethasone, and there is evidence that regular use of Beta 1-agonists has a useful suppressive effect. In severe chronic asthma high doses may be indicated and be effective where conventional doses have failed. The introduction of reliable sustained-release preparation of theophylline and its derivatives together with plasma assays theophylline levels has enabled therapy to be optimal and side effects to be lessened. The therapeutic range is a plasma concentration of 10-20 mg/l. There are large individual variations in hepatic clearance of theophylline, which may also be influenced by age, liver disease, drugs and viral infections. Theophyllines are less effective as bronchodilators than Beta 2-agonists but in chronic severe asthma have a place for their additive effect. They are used most frequently to suppress nocturnal asthma and early morning wheezing.

摘要

β2 激动剂最好通过吸入给药,因为这种给药途径能以最小的副作用提供最大的治疗效果。血浆水平较低,肌肉痉挛、心动过速和震颤也较少见。吸入可通过使用压力定量吸入器(必要时可进行各种改进)、带有沙丁胺醇粉末的旋转式吸入器以及雾化器来进行。各有其用途。除了其直接的支气管扩张作用外,通常在吸入倍氯米松之前常规给予β2 激动剂,而且有证据表明定期使用β2 激动剂有有益的抑制作用。在严重的慢性哮喘中,可能需要高剂量,且在常规剂量无效时可能有效。可靠的茶碱及其衍生物缓释制剂的引入以及血浆茶碱水平检测使治疗达到最佳效果并减少了副作用。治疗范围是血浆浓度为 10 - 20 毫克/升。茶碱的肝脏清除率存在很大的个体差异,这也可能受年龄、肝病、药物和病毒感染的影响。茶碱作为支气管扩张剂的效果不如β2 激动剂,但在慢性重度哮喘中因其相加作用而有一席之地。它们最常用于抑制夜间哮喘和清晨喘息。

相似文献

1
Bronchodilators: beta 2 agonists versus theophylline.支气管扩张剂:β2 激动剂与茶碱的比较
Ann Acad Med Singap. 1987 Apr;16(2):228-9.
2
Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?吸入性糖皮质激素无法控制的夜间哮喘:茶碱还是长效β2受体激动剂?
Drugs. 2001;61(3):391-418. doi: 10.2165/00003495-200161030-00007.
3
Long acting beta-agonists versus theophylline for maintenance treatment of asthma.长效β受体激动剂与茶碱用于哮喘维持治疗的比较
Cochrane Database Syst Rev. 2003(3):CD001281. doi: 10.1002/14651858.CD001281.
4
Controversies in asthma therapy with theophylline and the beta 2-adrenergic agonists.茶碱与β2肾上腺素能激动剂在哮喘治疗中的争议。
Clin Pharm. 1984 Jul-Aug;3(4):386-95.
5
Current therapies for asthma. Promise and limitations.
Chest. 1997 Feb;111(2 Suppl):17S-26S. doi: 10.1378/chest.111.2_supplement.17s.
6
Combination bronchodilator therapy.联合支气管扩张剂治疗
Drugs. 1982 Nov;24(5):414-39. doi: 10.2165/00003495-198224050-00004.
7
Pharmacokinetic optimisation of asthma treatment.哮喘治疗的药代动力学优化
Clin Pharmacokinet. 1994 May;26(5):396-418. doi: 10.2165/00003088-199426050-00006.
8
Long acting beta-agonists versus theophylline for maintenance treatment of asthma.长效β受体激动剂与茶碱用于哮喘维持治疗的比较
Cochrane Database Syst Rev. 2000(2):CD001281. doi: 10.1002/14651858.CD001281.
9
The role of theophyllines in a preventive approach for subjects with both mild and severe asthma.茶碱类药物在轻度和重度哮喘患者预防治疗中的作用。
Postgrad Med J. 1991;67 Suppl 4:S25-8; discussion S28-9.
10
Reassessment of the role of theophylline in the current therapy for nocturnal asthma.茶碱在当前夜间哮喘治疗中作用的重新评估。
J Am Board Fam Pract. 1992 May-Jun;5(3):281-8.